Neonc Technologies (NASDAQ:NTHI) CEO Purchases $45,480.00 in Stock

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI) CEO Amir Heshmatpour purchased 12,000 shares of the stock in a transaction on Friday, August 14th. The shares were acquired at an average cost of $3.79 per share, for a total transaction of $45,480.00. Following the transaction, the chief executive officer owned 3,084,000 shares of the company’s stock, valued at approximately $11,688,360. The trade was a 0.39% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Neonc Technologies Stock Performance

NASDAQ:NTHI opened at $4.63 on Thursday. Neonc Technologies Holdings, Inc. has a 12-month low of $3.01 and a 12-month high of $12.99. The stock’s 50 day moving average price is $4.14 and its two-hundred day moving average price is $5.99.

Neonc Technologies (NASDAQ:NTHI) last issued its earnings results on Friday, August 14th. The company reported ($0.58) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.46).

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. BTIG Research reaffirmed a “buy” rating and set a $15.00 price objective on shares of Neonc Technologies in a research report on Tuesday, May 26th. Maxim Group initiated coverage on shares of Neonc Technologies in a research report on Monday, May 18th. They issued a “buy” rating and a $20.00 price objective on the stock. Wall Street Zen cut shares of Neonc Technologies from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. Weiss Ratings downgraded shares of Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, June 24th. Finally, Alliance Global Partners assumed coverage on shares of Neonc Technologies in a report on Tuesday, May 19th. They set a “buy” rating and a $13.00 target price for the company. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $16.00.

Institutional Trading of Neonc Technologies

Several hedge funds have recently added to or reduced their stakes in NTHI. Bank of America Corp DE acquired a new position in Neonc Technologies in the 2nd quarter valued at $1,017,000. HighPoint Advisor Group LLC increased its position in Neonc Technologies by 20.5% during the 4th quarter. HighPoint Advisor Group LLC now owns 1,144,640 shares of the company’s stock worth $9,466,000 after buying an additional 194,408 shares during the period. BlackRock Inc. acquired a new stake in shares of Neonc Technologies during the second quarter worth $815,000. Westmount Partners LLC lifted its holdings in shares of Neonc Technologies by 355.2% during the second quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after buying an additional 153,858 shares in the last quarter. Finally, Vanguard Group Inc. bought a new stake in shares of Neonc Technologies in the third quarter valued at about $1,279,000.

About Neonc Technologies

Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.